DEXTROSE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE

FDA Drug Profile — Potassium Chloride in Dextrose and Sodium Chloride

DEXTROSE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including Potassium Chloride in Dextrose and Sodium Chloride. Available dosage form: injection.

Drug details

Generic Name
DEXTROSE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE
Brand Names
Potassium Chloride in Dextrose and Sodium Chloride
Application Number
NDA019630
Sponsor
B. Braun Medical Inc.
NDC Codes
6
Dosage Forms
INJECTION
Routes
INTRAVENOUS
Active Ingredients
DEXTROSE, UNSPECIFIED FORM, SODIUM CHLORIDE, POTASSIUM CHLORIDE

Indications and Usage

INDICATIONS AND USAGE These intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes, calories and water for hydration.

Warnings

WARNINGS The administration of intravenous solutions can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentration. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentration. Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there is sodium retention with edema. In patients with diminished renal function, administration of solutions containing sodium or potassium ions may result in sodium or potassium retention. Solutions containing potassium ions should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present. To avoid life-threatening hyperkalemia, do not administer Potassium Chloride in Dextrose and Sodium Chloride Injections USP as an intravenous push (i.e., intravenous injection manually with a syringe connected to the intravenous access, without a quantitative infusion device).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.